Article
Prospects and challenges of CRISPR /Cas9 gene‐editing technology in cancer research
14 Sept 2023
Abstract excerpt
Cancer, one of the leading causes of death, usually commences and progresses as a result of a series of gene mutations and dysregulation of expression. With the development of clustered regularly interspaced palindromic repeat (CRISPR)/Cas9 gene-editing technology, it is possible to edit and then decode the functions of cancer-related gene mutations, markedly advance the research of biological mechanisms and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
